Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CALL
Sempra
SRE
$56.6B
| $3.04M | ﹤0.01% |
68,400
-118,200
| -63% | -$5.25M |
|
2227
CALL
Rio Tinto
RIO
$161B
| $3.04M | ﹤0.01% |
54,300
-107,000
| -66% | -$5.57M |
|
|
PSXP
2228
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $3.04M | ﹤0.01% |
82,165
+62,123
| +310% | +$2.05M |
|
|
XEC
2229
DELISTED
CIMAREX ENERGY CO
XEC
| $3.04M | ﹤0.01% |
29,208
-61,553
| -68% | -$6.23M |
|
2230
United Rentals
URI
$71.6B
| $3.03M | ﹤0.01% |
39,390
-3,550
| -8% | -$238K |
|
|
WP
2231
DELISTED
Worldpay, Inc.
WP
| $3.03M | ﹤0.01% |
94,761
+89,372
| +1,658% | +$2.59M |
|
|
TFCF
2232
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $3.03M | ﹤0.01% |
89,133
-18,818
| -17% | -$628K |
|
|
BWLD
2233
PUT
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $3.03M | ﹤0.01% |
20,600
-48,400
| -70% | -$6.66M |
|
|
UHT
2234
Universal Health Realty Income Trust
UHT
$587M
| $3.02M | ﹤0.01% |
75,525
+30,459
| +68% | +$1.29M |
|
|
EXPR
2235
DELISTED
Express, Inc.
EXPR
| $3.02M | ﹤0.01% |
8,384
+2,747
| +49% | +$1.21M |
|
2236
CALL
Clorox
CLX
$12.7B
| $3.02M | ﹤0.01% |
32,800
-42,600
| -56% | -$3.84M |
|
|
RTN
2237
PUT
DELISTED
Raytheon Company
RTN
| $3.02M | ﹤0.01% |
33,500
-58,200
| -63% | -$4.86M |
|
2238
Invesco CEF Income Composite ETF
PCEF
$812M
| $3.01M | ﹤0.01% |
125,467
-3,030
| -2% | -$72.8K |
|
|
URS
2239
DELISTED
URS CORP
URS
| $3.01M | ﹤0.01% |
57,879
-2,496
| -4% | -$131K |
|
|
BGC
2240
DELISTED
General Cable Corporation
BGC
| $3.01M | ﹤0.01% |
103,686
+34,882
| +51% | +$1.06M |
|
|
LGF
2241
CALL
DELISTED
Lions Gate Entertainment
LGF
| $3M | ﹤0.01% |
96,900
+25,500
| +36% | +$841K |
|
|
CTRX
2242
PUT
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $3M | ﹤0.01% |
63,900
+20,600
| +48% | +$971K |
|
2243
CALL
Celldex Therapeutics
CLDX
$3.07B
| $3M | ﹤0.01% |
8,333
+4,293
| +106% | +$1.65M |
|
|
SEE
2244
CALL
DELISTED
Sealed Air
SEE
| $3M | ﹤0.01% |
88,200
+47,300
| +116% | +$1.44M |
|
|
UN
2245
DELISTED
Unilever NV New York Registry Shares
UN
| $3M | ﹤0.01% |
74,811
+15,868
| +27% | +$617K |
|
2246
CALL
M&T Bank
MTB
$36.7B
| $2.99M | ﹤0.01% |
25,800
+19,500
| +310% | +$2.22M |
|
2247
Alaska Air
ALK
$5.86B
| $2.99M | ﹤0.01% |
81,970
-11,782
| -13% | -$419K |
|
2248
CALL
Amphenol
APH
$211B
| $2.99M | ﹤0.01% |
268,800
+204,000
| +315% | +$2.11M |
|
|
JSD
2249
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $2.99M | ﹤0.01% |
166,142
-43,942
| -21% | -$818K |
|
2250
CALL
Ericsson
ERIC
$33.7B
| $2.99M | ﹤0.01% |
249,100
-3,200
| -1% | -$39.8K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.